Ann: Axiron Net Sales for the Quarter to 31 March, page-27

re: Ann: Axiron Net Sales for the Quarter to ... The Motley Fool comp is misleading as there is some seasonality in the Q figures. Take a look at the Q results todate.

Would be interested in view on Axiron taking more share - can they get to 20% of the market (or is 14% the best they can get)? certainly looking hard at this point given Androgel was the only mkt share gainer for the Quarter.

net sales (US$m): market share (%)
2011 Q1 0 0.0%
Q2 3.2 2.0%
Q3 5.3 6.0%
Q4 15.5 9.0%
2012 Q1 16.2 11.0%
Q2 17.7 12.0%
Q3 16 12.0%
Q4 23.9 13.0%
2013 Q1 37.1 14.1%
Q2 47.1 14.0%
Q3 40.6 14.3%
Q4 53.9 14.3%
2014 Q1 39.5 14.20%